Medicare Enrolled
Dr. Andrew Benn, MD
Interventional Cardiology · Walnut Creek, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Benn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Benn
Dr. Andrew Benn is an interventional cardiology specialist in Walnut Creek, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Benn performed 16,712 Medicare services across 4,245 unique beneficiaries.
Between the years covered by Open Payments, Dr. Benn received a total of $157,224 from 37 pharmaceutical and/or device companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Benn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$157,224 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,712
Medicare services
Top 3% in CA for interventional cardiology
4,245
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~880 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Inclisiran injection (Leqvio) for cholesterol | 10,224 | $9 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,085 | $106 | $305 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
788 | $7 | $26 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
722 | $69 | $138 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
625 | $22 | $83 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
455 | $13 | $106 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
337 | $193 | $917 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
330 | $154 | $406 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
287 | $24 | $140 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
217 | $26 | $138 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
186 | $105 | $347 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
178 | $70 | $222 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
119 | $148 | $461 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
104 | $57 | $169 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
103 | $22 | $112 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
100 | $23 | $163 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
86 | $228 | $897 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
84 | $60 | $440 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
71 | $32 | $247 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
69 | $200 | $805 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
68 | $154 | $585 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
59 | $18 | $70 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
59 | $12 | $61 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
59 | $21 | $162 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
59 | $77 | $204 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
49 | $108 | $412 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
41 | $70 | $254 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
35 | $13 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $72 | $210 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
23 | $87 | $305 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
21 | $13 | $280 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
18 | $22 | $79 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
14 | $61 | $278 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
13 | $13 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.7% high complexity
63.7% medium
29.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$157,224
Total received (2018-2024)
Avg $22,461/year across 7 years
Top 6% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
409
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152,893 (97.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,332 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,964
2023
$1,799
2022
$3,800
2021
$24,164
2020
$21,027
2019
$67,391
2018
$37,080
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$197
PFIZER INC.
$181
AstraZeneca Pharmaceuticals LP
$160
Lexicon Pharmaceuticals, Inc.
$147
E.R. Squibb & Sons, L.L.C.
$139
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$136
iRhythm Technologies, Inc.
$122
Kiniksa Pharmaceuticals International, plc
$95
Amgen Inc.
$82
Boston Scientific Corporation
$75
Abbott Laboratories
$74
Merck Sharp & Dohme LLC
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Bayer Healthcare Pharmaceuticals Inc.
$50
HEARTFLOW, INC.
$43
Edwards Lifesciences Corporation
$42
Actelion Pharmaceuticals US, Inc.
$38
Alnylam Pharmaceuticals Inc.
$38
Janssen Pharmaceuticals, Inc
$33
Esperion Therapeutics, Inc.
$32
ABIOMED
$31
SANOFI-AVENTIS U.S. LLC
$30
Regeneron Healthcare Solutions, Inc.
$21
ATRICURE, INC.
$18
Biogen, Inc.
$16
SCPHARMACEUTICALS INC.
$16
Kestra Medical Technology Services, Inc.
$14
Novo Nordisk Inc
$13
Top 3 companies account for 27.4% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$107,050
PORTOLA PHARMACEUTICALS, INC.
$18,707
E.R. Squibb & Sons, L.L.C.
$16,146
Boston Scientific Corporation
$8,955
Pfizer Inc.
$2,786
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$435
AstraZeneca Pharmaceuticals LP
$347
Novartis Pharmaceuticals Corporation
$333
HeartFlow, Inc.
$256
Amgen Inc.
$202
Merck Sharp & Dohme LLC
$189
Novo Nordisk Inc
$172
BIOTRONIK INC.
$169
Lexicon Pharmaceuticals, Inc.
$147
Janssen Pharmaceuticals, Inc
$140
Boehringer Ingelheim Pharmaceuticals, Inc.
$126
iRhythm Technologies, Inc.
$122
Impulse Dynamics (USA) Inc.
$112
Abbott Laboratories
$98
Kiniksa Pharmaceuticals International, plc
$95
Bayer Healthcare Pharmaceuticals Inc.
$87
Actelion Pharmaceuticals US, Inc.
$80
ATRICURE, INC.
$68
Alnylam Pharmaceuticals Inc.
$52
Kiniksa Pharmaceuticals, Ltd.
$47
HEARTFLOW, INC.
$43
Edwards Lifesciences Corporation
$42
Esperion Therapeutics, Inc.
$32
ABIOMED
$31
SANOFI-AVENTIS U.S. LLC
$30
Merck Sharp & Dohme Corporation
$22
Regeneron Healthcare Solutions, Inc.
$21
Relypsa, Inc.
$20
Lundbeck LLC
$18
Biogen, Inc.
$16
SCPHARMACEUTICALS INC.
$16
Kestra Medical Technology Services, Inc.
$14
Top 3 companies account for 90.3% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ANDEXXA · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · Acticor · Arcalyst · Assure WCD · BEVYXXA · CAMZYOS · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · ENTRESTO · EVKEEZA · Edora 8 DR-T · FARXIGA · FFRct · FUROSCIX · GALLANT · GENERAL THERAPIES · Impella · JARDIANCE · Kerendia · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · NEXLETOL · NORTHERA · OPSUMIT · OPTIMIZER · Ozempic · RESONATE · Repatha · Rybelsus · SKYCLARYS · VERQUVO · VYNDAQEL · Veltassa · WAINUA · WATCHMAN · XARELTO · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for interventional cardiology in CA.
Geographic Context
Interventional cardiologists within 10 mi
43
Per 100K population
3.7
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - WALNUT CREEK CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Benn is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Benn experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Benn performed 10,224 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benn receive payments from pharmaceutical companies?
Yes. Dr. Benn received a total of $157,224 from 37 companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benn's costs compare to other interventional cardiologists in Walnut Creek?
Dr. Benn's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Walnut Creek
Browse interventional cardiologists in Walnut Creek ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
PORTOLA PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from PORTOLA PHARMACEUTICALS, INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology